Journal of the Association of Nurses in AIDS Care
Volume 18, Issue 1, Supplement , Pages S11-S16 , January 2007

Current Clinical Issues Impacting the Lives of Patients Living With HIV/AIDS

  • Donna M. Gallagher, RNC, MSN, ANP, FAAN

      Affiliations

    • Donna M. Gallagher, RNC, MSN, ANP, FAAN, is Principal Investigator/Project Director, New England AIDS Education and Training Center, Boston, Massachusetts.

References 

  1. Amorosa V, Synnestvedt M, Gross R, Friedman H, MacGregor RR, Gudonis D, et al. A tale of 2 epidemics: The intersection between obesity and HIV infection in Philadelphia. Journal of Acquired Immune Deficiency Syndromes. 2005;39:557–561
  2. Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Archives of Internal Medicine. 2005;165:1179–1184
  3. Danoff A, Shi Q, Justman J, Mulligan K, Hessol N, Robinson E, et al. Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women. Journal of Acquired Immune Deficiency Syndromes. 2005;39:55–62
  4. Department of Health and Human Services. (2006). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Retrieved May 5, 2006, from http://www.aidsinfo.nih.gov/guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=7&ClassID=1
  5. El-Sadr WM, Mullin CM, Carr A, Gilbert C, Rappoport C, Visnegarwala F, et al. Effects of HIV disease on lipid, glucose and insulin levels: Results from a large antiretroviral-naive cohort. HIV Medicine. 2005;6:114–121
  6. Fichtenbaum CJ, Gerber JG, Rosenkranz SL, Segal Y, Aberg JA, Blaschke T, et al. Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047. AIDS. 2002;16:569–577
  7. Grinspoon S. Insulin resistance in the HIV-lipodystrophy syndrome. Trends in Endocrinology and Metabolism. 2001;12:413–419
  8. Jerico C, Knobel H, Montero M, Ordonez-Llanos J, Guelar A, Gimeno JL, et al. Metabolic syndrome among HIV-infected patients: Prevalence, characteristics, and related factors. Diabetes Care. 2005;28:132–137
  9. Johnson M, Grinsztejn B, Rodriguez C, Coco J, DeJesus E, Lazzarin A, et al. Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures. AIDS. 2005;19:153–162
  10. Lichtenstein KA. Redefining lipodystrophy syndrome: Risks and impact on clinical decision making. Journal of Acquired Immune Deficiency Syndromes. 2005;39:395–400
  11. Mallal SA, John M, Moore CB, James IR, McKinnon EJ. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS. 2000;14:1309–1316
  12. Mallon PW, Cooper DA, Carr A. HIV-associated lipodystrophy. HIV Medicine. 2001;2:166–173
  13. Murphy RL, Sanne I, Cahn P, Phanuphak P, Percival L, Kelleher T, et al. Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-week results. AIDS. 2003;17:2603–2614
  14. National Institute of Diabetes and Digestive and Kidney Diseases. (2005). National diabetes statistics. Retrieved April 24, 2005, from http://diabetes.niddk.nih.gov/dm/pubs/statistics/#9
  15. Purnell JQ, Zambon A, Knopp RH, Pizzuti DJ, Achari R, Leonard JM, et al. Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects. AIDS. 2000;14:51–57
  16. Riddler SA, Smit E, Cole SR, Li R, Chmiel JS, Dobs A, et al. Impact of HIV infection and HAART on serum lipids in men. Journal of the American Medical Association. 2003;289:2978–2982
  17. Shikuma CM, Day LJ, Gerschenson M. Insulin resistance in the HIV-infected population: The potential role of mitochondrial dysfunction. Current Drug Targets. Infectious Disorders. 2005;5:255–262
  18. Tierney A, Grunfeld C, Kotler DP, Shigenaga JK, Doerrler W, Wang J, et al. Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. American Journal of Medicine. 1991;90:154–162
  19. Umeh OC, Currier JS. Lipids, metabolic syndrome, and risk factors for future cardiovascular disease among HIV-infected patients. Current HIV/AIDS Reports. 2005;2:132–139

PII: S1055-3290(06)00318-9

doi: 10.1016/j.jana.2006.11.011

Journal of the Association of Nurses in AIDS Care
Volume 18, Issue 1, Supplement , Pages S11-S16 , January 2007

Article Tools

* Image Usage & Resolution